June 8 (Reuters) - Terveystalo Oyj TTALO.HE :
* INSIDE INFORMATION: TERVEYSTALO TO ACQUIRE SILMÄASEMA TO
ACCELERATE GROWTH AND INCREASE PRESENCE IN THE GROWING EYE CARE
MARKET
* CORONARIA TO BECOME LARGEST SHAREHOLDER OF TERVEYSTALO
WITH 15.1% HOLDING
* COMBINED COMPANY TO HAVE EUR 1.55 BILLION REVENUE AND EUR
193 MILLION ADJUSTED EBIT FOR 2025
* SELLERS TO HOLD 22.4% OF TERVEYSTALO SHARES UPON
COMPLETION
* DEAL EXPECTED TO GENERATE EUR 11–15 MILLION ANNUAL PRE-TAX
RUN-RATE SYNERGIES BY YEAR THREE
* ONE-OFF INTEGRATION COSTS EXPECTED AT EUR 7–9 MILLION
* SILMÄASEMA GENERATED EUR 267 MILLION REVENUE AND EUR 37
MILLION ADJUSTED EBIT IN 2025
Source text: ID:nWkr7f8hQ0
Further company coverage: TTALO.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))